Brady Corp: Form 10-Q for the period ended Jan 31, 2021
Filed with the SEC on Feb 18, 2021 and accepted by EDGAR at Feb 18, 2021, 07:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-11-01 to 2021-01-31 | $265.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2020-08-01 to 2021-01-31 | $543.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-11-01 to 2021-01-31 | $136.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2020-08-01 to 2021-01-31 | $278.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-11-01 to 2021-01-31 | $129.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2020-08-01 to 2021-01-31 | $264.9m | us-gaap:GrossProfit |
| Research and development | 3 months2020-11-01 to 2021-01-31 | $9.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2020-08-01 to 2021-01-31 | $20.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-11-01 to 2021-01-31 | $82.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-08-01 to 2021-01-31 | $165.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-11-01 to 2021-01-31 | $37.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-08-01 to 2021-01-31 | $79.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-11-01 to 2021-01-31 | $51.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2020-08-01 to 2021-01-31 | $157.0k | us-gaap:InterestExpense |
| Income tax | 3 months2020-11-01 to 2021-01-31 | $8.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-08-01 to 2021-01-31 | $16.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-11-01 to 2021-01-31 | $30.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-08-01 to 2021-01-31 | $64.3m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2020-11-01 to 2021-01-31 | 52,282,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-08-01 to 2021-01-31 | 52,288,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-08-01 to 2021-01-31 | $98.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-08-01 to 2021-01-31 | $14.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2020-08-01 to 2021-01-31 | $22.8m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2020-08-01 to 2021-01-31 | $3.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-01-31 | $277.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-01-31 | $567.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-01-31 | $1.21bn | us-gaap:Assets |
| Current liabilities | At period end2021-01-31 | $201.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-01-31 | $288.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-01-31 | $919.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000746598-21-000023. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.